MRK vs QURE · P/E 33, rev $16.61B vs rev $16.1M
Merck & Company Inc (MRK) versus Uniqure NV (QURE) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Uniqure NV (QURE) is a biotechnology company listed on NASDAQ.
Latest reported MRK revenue for 2026-06-30 was $16.61B. Net income was -$1.33B. Revenue was up 2.0% from 2026-03-31 to 2026-06-30. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported QURE revenue for 2025-12-31 was $16.1M. Net income was -$199.0M. Revenue was down 40.6% from 2024-12-31 to 2025-12-31. QURE currently screens at market cap $3.04B.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. QURE currently screens at market cap $3.04B.
Not investment advice. Open the MRK and QURE stock pages for the full models.
Not investment advice.